Target intelligence / Profile preview

Systemic plasma electrolyte and acid-base composition

Molecular classification
Physiological system, Homeostatic parameter
01

Overview

Systemic plasma electrolyte and acid-base composition refers to the tightly regulated concentrations of ions and the hydrogen ion balance within the blood plasma. This homeostatic state is vital for maintaining cellular membrane potential, enzymatic function, and overall metabolic stability (StatPearls, NBK541123). The regulation of these parameters is primarily managed by the kidneys and lungs through the excretion of metabolic waste and the retention of essential buffers like bicarbonate (StatPearls, NBK507807). While not a single molecular target, this composition is a primary clinical endpoint for therapies addressing renal failure, heart failure, and metabolic disorders. Drugs such as diuretics, alkalizing agents, and ion-exchange resins are frequently employed to manipulate these levels by acting on specific transporters and enzymes. Imbalances in this system, such as hyperkalemia or metabolic acidosis, can lead to severe clinical outcomes including cardiac arrhythmias and neurological dysfunction. Consequently, monitoring these levels is a cornerstone of critical care and chronic disease management.

Other names
Acid-base homeostasisPlasma electrolyte balanceSerum electrolyte compositionBlood pH and electrolyte status
02

Mechanism of action

Drugs modulate systemic composition by targeting specific molecular entities such as the Na-K-2Cl symporter (NKCC2) in the loop of Henle, carbonic anhydrase in the proximal tubule, or the mineralocorticoid receptor in the distal nephron to alter the excretion or retention of ions and water (StatPearls, NBK541123).

03

Biological functions

HomeostasispH regulationOsmoregulationElectrochemical signalingEnzymatic cofactor regulation
04

Disease associations

Metabolic acidosisMetabolic alkalosisHyponatremiaHyperkalemiaChronic kidney diseaseHeart failure
05

Safety considerations

Cardiac arrhythmiaCerebral edemaNeurological impairmentOsmotic demyelination syndromeMetabolic decompensation
06

Interacting drugs

Furosemide

6 more in the full profile.

07

Biomarkers

Serum sodiumSerum potassiumSerum bicarbonateArterial blood gas (ABG) pHAnion gap

Beyond the preview

Go deeper on Systemic plasma electrolyte and acid-base composition.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic plasma electrolyte and acid-base composition.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call